Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N. Engl. J. Med, vol.366, pp.883-892, 2012. ,
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing, Nat. Genet, vol.46, pp.225-233, 2014. ,
Investigating intratumour heterogeneity by single-cell sequencing, Asian J. Androl, vol.15, pp.729-734, 2013. ,
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes, Clin. Cancer Res, vol.13, pp.2329-2334, 2007. ,
The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy, Biomaterials, vol.33, pp.2961-2970, 2012. ,
Stem cells increase in numbers in perinecrotic areas in human renal cancer, Clin. Cancer Res, vol.21, pp.916-924, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02142795
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer, Oncotarget, vol.8, pp.35205-35221, 2017. ,
Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells, Stem Cell Rep, vol.9, pp.464-477, 2017. ,
Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells, Cancer Res, vol.66, pp.9339-9344, 2006. ,
Looking ahead in cancer stem cell research, Nat. Biotechnol, vol.27, pp.44-46, 2009. ,
Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy, Sci. Transl. Med, vol.2, 2010. ,
Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer, Biomed. Res. Int, p.981261, 2014. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4048, 2018.
Regulation of ovarian cancer stem cells or tumor-initiating cells, Int. J. Mol. Sci, vol.14, pp.6624-6648, 2013. ,
Cancer stem cells: Models and concepts, Annu. Rev. Med, vol.58, pp.267-284, 2007. ,
Tumour stem cells and drug resistance, Nat. Rev. Cancer, vol.5, pp.275-284, 2005. ,
Deadly teamwork: Neural cancer stem cells and the tumor microenvironment, Cell Stem Cell, vol.8, pp.482-485, 2011. ,
Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells, Cell Stem Cell, vol.6, pp.141-152, 2010. ,
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression, Trends Cancer, vol.2, pp.758-770, 2016. ,
Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response, Anticancer Res, vol.34, pp.2957-2966, 2014. ,
Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model, PLoS ONE, vol.4, p.6381, 2009. ,
PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells, Cell Stem Cell, vol.4, pp.226-235, 2009. ,
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance, Int. J. Mol. Sci, vol.18, p.2362, 2017. ,
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade, Drug Resist. Updates, vol.18, pp.1-17, 2015. ,
Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells, Oncol. Lett, vol.9, pp.1287-1292, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02378731
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy, J. Hematol. Oncol, vol.6, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00845842
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype, Cell Cycle, vol.11, pp.1966-1976, 2012. ,
Identification and characterization of ovarian cancer-initiating cells from primary human tumors, Cancer Res, vol.68, pp.4311-4320, 2008. ,
Characterization of stem cell-like cancer cells in immune-competent mice, Blood, vol.108, pp.3906-3912, 2006. ,
Somatic stem cells of the ovary and their relationship to human ovarian cancers, StemBook; Harvard Stem Cell Institute, 2008. ,
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics, Oncotarget, vol.5, pp.7027-7039, 2014. ,
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness, Proc. Natl. Acad. Sci, vol.103, pp.11154-11159, 2006. ,
Characterization of a side population of cancer cells from human gastrointestinal system, Stem Cells, vol.24, pp.506-513, 2006. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4049, 2018.
Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proc. Natl. Acad. Sci, vol.101, pp.781-786, 2004. ,
Cancer stem cell characteristics in retinoblastoma, Mol. Vis, vol.11, pp.729-737, 2005. ,
Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population, PLoS ONE, vol.8, 2013. ,
A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells, Mol. Cancer Ther, vol.11, pp.1863-1872, 2012. ,
RNA binding protein RBM14 promotes radio-resistance in glioblastoma by regulating DNA repair and cell differentiation, Oncotarget, vol.5, pp.2820-2826, 2014. ,
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells, Cell Death Differ, vol.21, pp.258-269, 2014. ,
Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells, Proc. Natl. Acad. Sci, vol.112, pp.4411-4416, 2015. ,
p53 protein aggregation promotes platinum resistance in ovarian cancer, Oncogene, vol.34, pp.3605-3616, 2015. ,
DNA Damage in Stem Cells, Mol. Cell, vol.66, pp.306-319, 2017. ,
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: A phase 2, multicentre, open-label, non-randomised study, Lancet Oncol, vol.12, pp.852-861, 2011. ,
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer, N. Engl. J. Med, vol.366, pp.1382-1392, 2012. ,
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation, N. Engl. J. Med, vol.377, pp.523-533, 2017. ,
Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells, Breast Cancer, vol.21, pp.75-85, 2014. ,
Phase, I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors, Ann. Oncol, vol.25, pp.1656-1663, 2014. ,
First-in-human phase, I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma, Br. J. Cancer, vol.114, pp.1199-1205, 2016. ,
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells, J. Clin. Investig, vol.127, pp.2392-2406, 2017. ,
PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma, PLoS ONE, vol.9, 2014. ,
ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib, PLoS ONE, vol.9, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01431935
, Int. J. Mol. Sci, vol.19, pp.4036-4050, 2018.
Epithelial-mesenchymal transitions in tumour progression, Nat. Rev. Cancer, vol.2, pp.442-454, 2002. ,
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients, Oncotarget, vol.6, pp.41497-41507, 2015. ,
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy, Cold Spring Harb. Symp. Quant. Biol, vol.81, pp.11-19, 2016. ,
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer, Molecules, vol.21, p.965, 2016. ,
Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation, PLoS ONE, vol.11, 2016. ,
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation, Mol. Cancer, vol.16, issue.10, 2017. ,
Epithelial-to-mesenchymal plasticity of cancer stem cells: Therapeutic targets in hepatocellular carcinoma, J. Hematol. Oncol, vol.9, 2016. ,
Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma, Oncotarget, vol.6, pp.19279-19289, 2015. ,
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship, Clin. Cancer Res, vol.9, pp.327-337, 2003. ,
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis, Cancer Chemother. Pharmacol, vol.72, pp.1183-1193, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02142772
Metastatic renal carcinoma: Evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT, Radiology, vol.256, pp.511-518, 2010. ,
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma, J. Clin. Oncol, vol.27, pp.3584-3590, 2009. ,
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting, Clin. Cancer Res, vol.21, pp.1329-1339, 2015. ,
, Angiogenesis. J. Biol. Chem, vol.267, pp.10931-10934, 1992.
Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma, J. Exp. Clin. Cancer Res, vol.36, p.41, 2017. ,
Wnt/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance, Genes Dis, vol.3, pp.11-40, 2016. ,
Identifying and targeting cancer stem cells in the treatment of gastric cancer, vol.123, pp.1303-1312, 2017. ,
Cancer stem cell signaling pathways, Medicine, vol.2016, pp.8-19 ,
Targeting Hedgehog-A cancer stem cell pathway, Clin. Cancer Res, vol.16, pp.3130-3140, 2010. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4051, 2018.
Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: Conditional skin tumorigenesis recapitulates the hair growth cycle, Genes Dev, vol.19, pp.214-223, 2005. ,
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity, Curr. Biol, vol.17, pp.165-172, 2007. ,
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion, EMBO Mol. Med, vol.1, pp.338-351, 2009. ,
Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells, Blood, vol.123, pp.2826-2837, 2014. ,
STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells, Stem Cells, vol.27, pp.2383-2392, 2009. ,
Notch signalling in solid tumours: A little bit of everything but not all the time, Nat. Rev. Cancer, vol.11, pp.338-351, 2011. ,
The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer, PLoS ONE, vol.9, 2014. ,
Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma, Cancer Res, vol.74, pp.6364-6374, 2014. ,
Notch promotes radioresistance of glioma stem cells, Stem Cells, vol.28, pp.17-28, 2010. ,
Wnt signaling in cancer, Cold Spring Harb. Perspect. Biol, vol.4, 2012. ,
Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling, Nature, vol.452, pp.650-653, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00283101
Blockade of Wnt/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype, Sci. Rep, vol.5, 2015. ,
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/beta-catenin-ATP-binding cassette G2 signaling, Oncogene, vol.32, pp.2767-2781, 2013. ,
Inactivation of the phosphatidylinositol 3-kinase/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells, J. Cell. Biochem, vol.116, pp.1080-1089, 2015. ,
A PI3K p110beta-Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis, Nat. Commun, vol.6, 2015. ,
MiR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation, EMBO Rep, vol.17, 1081. ,
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: Clinical update, Nat. Rev. Clin. Oncol, vol.12, pp.445-464, 2015. ,
Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population, Cancer Res, vol.76, pp.440-452, 2016. ,
Shared principles in NF-kappaB signaling, Cell, vol.132, pp.344-362, 2008. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4052, 2018.
NF-kappaB and cancer: How intimate is this relationship, Mol. Cell. Biochem, vol.336, pp.25-37, 2010. ,
Deletion of the NF-kappaB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function, Blood, vol.121, pp.5015-5024, 2013. ,
Noncanonical NF-kappaB signaling regulates hematopoietic stem cell self-renewal and microenvironment interactions, Stem Cells, vol.30, pp.709-718, 2012. ,
IKKbeta Enforces a LIN28B/TCF7L2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis, Cancer Res, vol.75, pp.1725-1735, 2015. ,
The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion, Cancer Res, vol.70, pp.10464-10473, 2010. ,
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma, N. Engl. J. Med, vol.361, pp.1164-1172, 2009. ,
CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance, Clin. Cancer Res, vol.20, pp.3974-3988, 2014. ,
Efficacy and safety of vismodegib in advanced basal-cell carcinoma, N. Engl. J. Med, vol.366, pp.2171-2179, 2012. ,
Targeting glioma-initiating cells in GBM: ABTC-0904, a randomized phase 0/II study targeting the Sonic Hedgehog-signaling pathway, J. Clin. Oncol, vol.32, 2014. ,
Suppression of cancer relapse and metastasis by inhibiting cancer stemness, Proc. Natl. Acad. Sci, vol.112, pp.1839-1844, 2015. ,
Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin, Cancer Med, vol.5, pp.1251-1258, 2016. ,
The BRIGHTER trial: A phase III randomized double-blind study of BBI608 + weekly paclitaxel versus placebo (PBO) + weekly paclitaxel in patients (pts) with pretreated advanced gastric and gastro-esophageal junction (GEJ) adenocarcinoma, J. Clin. Oncol, p.33, 2015. ,
A clinical trial protocol paper discussing the BRIGHTER study, Future Oncol, vol.14, pp.901-906, 2018. ,
A randomized phase III study of napabucasin [BBI608] (NAPA) vs. placebo (PBO) in patients (pts) with pretreated advanced colorectal cancer (ACRC): The CCTG/AGITG CO.23 trial, Ann. Oncol, vol.2016 ,
Identification of gastric cancer stem cells using the cell surface marker CD44, Stem Cells, vol.27, pp.1006-1020, 2009. ,
Identification of pancreatic cancer stem cells, Cancer Res, vol.67, pp.1030-1037, 2007. ,
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, Proc. Natl. Acad. Sci, vol.104, pp.973-978, 2007. ,
Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance, Cell Cycle, vol.8, pp.158-166, 2009. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4053, 2018.
All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth, Oncogene, vol.35, pp.5619-5628, 2016. ,
Prognostic significance of CD44v6/v7 in acute promyelocytic leukemia. Asian Pac, J. Cancer Prev, vol.13, pp.3791-3794, 2012. ,
Differentially expressed miRNAs in cancer-stem-like cells: Markers for tumor cell aggressiveness of pancreatic cancer, Stem Cells Dev, vol.23, pp.1947-1958, 2014. ,
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity, Proc. Natl. Acad. Sci, vol.105, pp.13427-13432, 2008. ,
Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma, PLoS ONE, vol.9, 2014. ,
Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci, vol.100, pp.3983-3988, 2003. ,
Upregulation of Mad2 facilitates in vivo and in vitro osteosarcoma progression, Oncol. Rep, vol.28, pp.2170-2176, 2012. ,
KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation, Appl. Immunohistochem. Mol. Morphol, vol.13, pp.205-220, 2005. ,
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome, Exp. Mol. Pathol, vol.91, pp.596-602, 2011. ,
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma, Clin. Cancer Res, vol.14, pp.4085-4095, 2008. ,
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells, Oncogene, vol.28, pp.209-218, 2009. ,
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer, Stem Cells, vol.27, pp.2875-2883, 2009. ,
The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells, Cancer Res, vol.68, pp.9703-9711, 2008. ,
Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer, Gastric Cancer, vol.15, pp.440-450, 2012. ,
Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer, Gastric Cancer, vol.17, pp.97-106, 2014. ,
Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study, Oncotarget, vol.7, pp.62049-62069, 2016. ,
Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma, Clin. Cancer Res, vol.23, pp.1586-1597, 2017. ,
Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor, PLoS ONE, vol.3, 2008. ,
Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1, Oncotarget, vol.2, pp.1028-1042, 2011. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4054, 2018.
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells, Oncogene, vol.29, pp.2672-2680, 2010. ,
Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-beta, J. Pathol, vol.228, pp.391-404, 2012. ,
ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy, Br. J. Cancer, vol.110, pp.430-434, 2014. ,
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival, Cancer Res, vol.71, pp.3991-4001, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01431946
Novel triplepositive markers identified in human nonsmall cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics, Oncol. Rep, vol.40, pp.669-681, 2018. ,
Stem cells, colorectal cancer and cancer stem cell markers correlations, Curr. Health Sci. J, vol.40, pp.153-161, 2014. ,
Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells, PLoS ONE, vol.10, 2015. ,
Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential, Cell Prolif, vol.43, pp.445-456, 2010. ,
Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer, Cancer Res, vol.66, pp.2181-2187, 2006. ,
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone, Cancer Res, vol.62, pp.1832-1837, 2002. ,
Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3), Cancer Res, vol.72, pp.24-32, 2012. ,
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance, Proc. Natl. Acad. Sci, vol.109, pp.2358-2363, 2012. ,
Identification of a tumor-initiating stem cell population in human renal carcinomas, FASEB J, vol.22, pp.3696-3705, 2008. ,
Identification of CD105 (endoglin)-positive stem-like cells in rhabdoid meningioma, J. Neurooncol, vol.106, pp.505-517, 2012. ,
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer, Clin. Cancer Res, vol.19, pp.170-182, 2013. ,
Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells, Mol. Carcinog, vol.56, pp.2499-2511, 2017. ,
Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients, Cell Res, vol.22, pp.248-258, 2012. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4055, 2018.
Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies ,
Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells, Ann. Surg. Oncol, vol.19, pp.1357-1364, 2012. ,
LGR5-Targeted Antibody-Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence, Mol. Cancer Ther, vol.15, pp.1580-1590, 2016. ,
Intestinal stem cell marker LGR5 expression during gastric carcinogenesis, World J. Gastroenterol, vol.19, pp.8714-8721, 2013. ,
Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer, J. Biol. Chem, vol.288, pp.16476-16483, 2013. ,
Oct4, a novel marker for human gastric cancer, J. Surg. Oncol, vol.99, pp.414-419, 2009. ,
Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin, Gynecol. Oncol, vol.121, pp.390-394, 2011. ,
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination, Semin. Cancer Biol, vol.18, pp.260-267, 2008. ,
From adhesion molecules to signalling regulators, Nat. Rev. Mol. Cell Biol, vol.4, pp.33-45, 2003. ,
A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms, Cell Death Differ, vol.13, pp.465-477, 2006. ,
Understanding the dual nature of CD44 in breast cancer progression, Mol. Cancer Res, vol.9, pp.1573-1586, 2011. ,
Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer, Clin. Cancer Res, vol.22, pp.670-679, 2016. ,
Characterization of a subpopulation of colon cancer cells with stem cell-like properties, Int. J. Cancer, vol.124, pp.1312-1321, 2009. ,
Targeting BMI1(+) Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma, Cell Stem Cell, vol.20, pp.621-634, 2017. ,
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma, Gynecol. Oncol, vol.136, pp.112-120, 2015. ,
Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer, Oncotarget, vol.6, pp.9313-9326, 2015. ,
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis, Cell Stem Cell, vol.14, pp.342-356, 2014. ,
Phase, I.I. Trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211), Int. J. Gynecol. Cancer, vol.17, pp.784-788, 2007. ,
Tumour-initiating cells vs. cancer 'stem' cells and CD133: What's in the name?, Biochem. Biophys. Res. Commun, vol.355, pp.855-859, 2007. ,
, Int. J. Mol. Sci, vol.19, p.24, 2018.
CD133 expression associated with poor prognosis in ovarian cancer, Mod. Pathol, vol.25, pp.456-464, 2012. ,
Isolation and characterization of tumor stem-like cells from human meningiomas, J. Neurooncol, vol.104, pp.45-53, 2011. ,
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases, Clin. Cancer Res, vol.12, pp.4859-4866, 2006. ,
Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo, Clin. Immunol, vol.149, pp.156-168, 2013. ,
Anti-human CD133 monoclonal antibody that could inhibit the proliferation of colorectal cancer cells, Hybridoma, vol.29, pp.305-310, 2010. ,
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer, Oncotarget, vol.8, pp.76044-76056, 2017. ,
Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells, J. Control, vol.269, pp.245-257, 2018. ,
CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis, Mol. Cancer Ther, vol.14, pp.1717-1727, 2015. ,
An emerging question about putative cancer stem cells in established cell lines-are they true stem cells or a fluctuating cell phenotype?, J. Cancer Stem Cell Res, vol.3, 2015. ,
COX-2, and p53 in epithelial ovarian cancer and its clinical significance, Front. Biosci, vol.4, pp.2645-2651, 2012. ,
CD44+/CD24? ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival, Clin. Exp. Metastasis, vol.29, pp.939-948, 2012. ,
Engineering a high-affinity humanized anti-CD24 antibody to target hepatocellular carcinoma by a novel CDR grafting design, Oncotarget, vol.8, pp.51238-51252, 2017. ,
Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform, Cell Cycle, vol.10, pp.1378-1384, 2011. ,
Prognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: A meta-analysis, PLoS ONE, vol.8, 2013. ,
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer, Mol. Cancer Ther, vol.9, pp.3186-3199, 2010. ,
The emerging role of EpCAM in cancer and stem cell signaling, Cancer Res, vol.69, pp.5627-5629, 2009. ,
Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: Implications for epithelial cell adhesion molecule-specific immunotherapy, Int. J. Gynecol. Cancer, vol.19, pp.860-866, 2009. ,
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer, Oncotarget, vol.7, pp.55771-55788, 2016. ,
An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer, Oncotarget, vol.6, pp.24947-24968, 2015. ,
Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells, Oncotarget, vol.3, pp.22-30, 2012. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4057, 2018.
Biomarker discovery for renal cancer stem cells, J. Pathol. Clin. Res, vol.4, pp.3-18, 2018. ,
Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: A meta-analysis, Oncotarget, vol.7, pp.65862-65875, 2016. ,
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma, Oncologist, 2018. ,
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma, Clin. Cancer Res, vol.23, pp.4633-4641, 2017. ,
A phase I. study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer, BJU Int, vol.116, pp.546-555, 2015. ,
A Phase, II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma, Clin. Genitourin. Cancer, vol.15, pp.77-85, 2017. ,
An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer, Clin. Cancer Res, vol.20, pp.5918-5926, 2014. ,
Human skin carcinoma arising from kidney transplant-derived tumor cells, J. Clin. Investig, vol.123, pp.3797-3801, 2013. ,
Donor-derived keratinocytes in actinic keratosis and squamous cell carcinoma in patients with kidney transplant, J. Investig. Dermatol, vol.133, pp.1108-1111, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-01397779
, Nanotechnology in Drugs, 2008.
Nanoparticles as drug delivery systems, Pharmacol. Rep, vol.64, pp.1020-1037, 2012. ,
Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS, Clin. Oncol, vol.6, pp.294-296, 1994. ,
Liposomal drug delivery systems: From concept to clinical applications, Adv. Drug Deliv. Rev, vol.65, pp.36-48, 2013. ,
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer, J. Clin. Oncol, vol.23, pp.7794-7803, 2005. ,
Engineered nanoparticles for drug delivery in cancer therapy, Angew. Chem. Int. Ed. Engl, vol.53, pp.12320-12364, 2014. ,
From "banghasomes" to liposomes: A memoir of Alec Bangham, FASEB J, vol.24, pp.1308-1310, 2010. ,
Single bilayer liposomes prepared without sonication, Biochim. Biophys. Acta, vol.298, pp.1015-1019, 1973. ,
Liposomes as carriers of enzymes or drugs: A new approach to the treatment of storage diseases, Biochem. J, vol.124, 1971. ,
Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B Biointerfaces, vol.75, pp.1-18, 2010. ,
PLGA Nanoparticles and Polysorbate-80-Coated PLGA Nanoparticles Increase the In vitro Antioxidant Activity of Melatonin, Curr. Drug Deliv, vol.15, pp.554-563, 2018. ,
, Int. J. Mol. Sci, vol.19, pp.4036-4058, 2018.
PEGylation, successful approach to drug delivery, Drug Discov. Today, vol.10, pp.1451-1458, 2005. ,
A new procedure for the preparation of liposomal doxorubicin: Biological activity in multidrug-resistant tumor cells, Cancer Chemother. Pharmacol, vol.35, pp.84-88, 1994. ,
Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin, Cancer Chemother. Pharmacol, vol.80, pp.737-743, 2017. ,
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma, Cancer Res, vol.58, pp.3320-3330, 1998. ,
Anti-HER2 immunoliposomes: Enhanced efficacy attributable to targeted delivery, Clin. Cancer Res, vol.8, pp.1172-1181, 2002. ,
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles, Cancer Lett, vol.239, pp.129-135, 2006. ,
Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model, Nanotechnology, vol.25, p.295102, 2014. ,
Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer, J. Photochem. Photobiol. B, vol.170, pp.58-64, 2017. ,
Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells, Int. J. Pharm, vol.549, pp.397-403, 2018. ,
The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues, Semin. Cancer Biol, vol.9, pp.67-81, 1999. ,
Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer, Int. J. Surg, vol.16, pp.123-128, 2015. ,
In vivo Distribution of Inorganic Nanoparticles in Preclinical Models, J. Biomater. Nanobiotechnol, vol.3, pp.269-279, 2012. ,
In vivo uptake and cellular distribution of gold nanoshells in a preclinical model of xenografted human renal cancer, vol.46, pp.257-265, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02316735
Gold Nanoparticles in Diagnostics and Therapeutics for Human Cancer, Int. J. Mol. Sci, vol.19, 1979. ,
Nanoparticles for thermal cancer therapy, J. Biomech. Eng, vol.131, p.74001, 2009. ,
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice, Cancer Lett, vol.269, pp.57-66, 2008. ,
Cellular responses to hyperthermia (40-46 degrees C): Cell killing and molecular events, Int. J. Hyperth, vol.24, pp.3-15, 2008. ,
Possible benefits of hyperthermia to chemotherapy, Cancer Res, vol.39, pp.2285-2289, 1979. ,
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer, Anticancer Res, vol.35, pp.4997-5005, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02326390
Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis, Cardiovasc. Interv. Radiol, vol.41, pp.1189-1204, 2018. ,
Selective cell targeting with light-absorbing microparticles and nanoparticles, Biophys. J, vol.84, pp.4023-4032, 2003. ,
Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol, vol.2, pp.751-760, 2007. ,
Near infrared light responsive hybrid nanoparticles for synergistic therapy, Biomaterials, vol.100, pp.76-90, 2016. ,
Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil, Int. J. Pharm, vol.516, pp.61-70, 2017. ,
Nanoparticles as carriers for drug delivery in cancer, Artif. Cells Nanomed. Biotechnol, pp.1-11, 2018. ,
Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, pp.177-182, 1987. ,
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors, J. Clin. Oncol, vol.30, pp.593-599, 2012. ,
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer, N. Engl. J. Med, vol.366, pp.109-119, 2012. ,
Trastuzumab emtansine for HER2-positive advanced breast cancer, N. Engl. J. Med, vol.367, pp.1783-1791, 2012. ,
HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer, Nanomedicine, vol.14, pp.1919-1929, 2018. ,
Pulsed Laser Irradiation of Multifunctional Gold Nanoshells to Overcome Trastuzumab Resistance in HER2-Overexpressing Breast Cancer ,
URL : https://hal.archives-ouvertes.fr/inserm-02528127
Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells, Colloids Surf. B Biointerfaces, vol.171, pp.150-158, 2018. ,
Hyperspectral darkfield microscopy of PEGylated gold nanoparticles targeting CD44-expressing cancer cells, J. Biophotonics, vol.8, pp.162-167, 2015. ,
Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133, Acta Biomater, vol.47, pp.182-192, 2017. ,
CD44v6 Monoclonal Antibody-Conjugated Gold Nanostars for Targeted Photoacoustic Imaging and Plasmonic Photothermal Therapy of Gastric Cancer Stem-like Cells, Theranostics, vol.5, pp.970-984, 2015. ,
Locoregional Confinement and Major Clinical Benefit of (188)Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma, vol.7, pp.4517-4536, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01631431
Human Induced Pluripotent Stem Cells for Tumor Targeted Delivery of Gold Nanorods and Enhanced Photothermal Therapy, ACS Nano, vol.10, pp.2375-2385, 2016. ,
Anticancer therapeutics: Targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor, Mol. Pharm, vol.5, pp.474-486, 2008. ,
Hyaluronic Acid Bioconjugates for the Delivery of Bioactive Molecules, Polymers, vol.6, pp.346-369, 2014. ,
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target, Stem Cells Transl. Med, vol.4, pp.1033-1043, 2015. ,
Immediate and Long-term Results of Radiofrequency Ablation for Colorectal Liver Metastases, Anticancer Res, vol.37, pp.6489-6494, 2017. ,
Quantification of the effect of electrical and thermal parameters on radiofrequency ablation for concentric tumour model of different sizes, J. Therm. Biol, vol.51, pp.23-32, 2015. ,
Heat shock protein expression and temperature distribution in prostate tumours treated with laser irradiation and nanoshells, Int. J. Hyperth, vol.27, pp.791-801, 2011. ,
Coinhibition of overexpressed genes in acute myeloid leukemia subtype M2 by gold nanoparticles functionalized with five antisense oligonucleotides and one anti-CD33(+)/CD34(+) aptamer, Cancer Gene Ther, vol.23, pp.315-320, 2016. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2018 by the authors. Licensee MDPI